Webinar

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?

Published

Format: External webinar | Document type: Webinar

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
The FDA recently authorized a level C qualified health claim for high-amylose maize resistant starch and a reduced risk of type 2 diabetes. The CDC reports that 1 in 3 American adults have prediabetes and are at risk for developing type 2 diabetes1—with 60% of consumers interested in buying foods that help them “reduce the risk of type 2 diabetes”2. Learn about this qualified health claim, and find out how HI-MAIZE® resistant starch can help you create innovative products.                    1 Click here for CDC reference                    2 Ingredion proprietary consumer research

Speakers

Maria Stewart, PhD Maria Stewart, PhD Clinical Research Lead, Global Nutrition R&D
Ingredion

Santiago Vega, MBA Santiago Vega, MBA Senior Marketing Manager, Nutrition North America
Ingredion

Supplier info centre